VEGF-A and
nitric oxide are essential for glomerular filtration barrier homeostasis and are dysregulated in
diabetic nephropathy. Here, we examined the effect of excess podocyte
VEGF-A on the renal phenotype of
endothelial nitric oxide synthase (eNOS) knockout mice. Podocyte-specific
VEGF(164) gain of function in eNOS(-/-) mice resulted in
nodular glomerulosclerosis, mesangiolysis,
microaneurysms, and arteriolar hyalinosis associated with massive
proteinuria and
renal failure in the absence of diabetic milieu or
hypertension. In contrast, podocyte-specific
VEGF(164) gain of function in wild-type mice resulted in less pronounced
albuminuria and increased
creatinine clearance. Transmission electron microscopy revealed glomerular basement membrane thickening and podocyte effacement in eNOS(-/-) mice with podocyte-specific
VEGF(164) gain of function. Furthermore, glomerular nodules overexpressed
collagen IV and
laminin extensively.
Biotin-switch and proximity
ligation assays demonstrated that podocyte-specific
VEGF(164) gain of function decreased glomerular S-nitrosylation of
laminin in eNOS(-/-) mice. In addition, treatment with
VEGF-A decreased S-nitrosylated
laminin in cultured podocytes. Collectively, these data indicate that excess glomerular
VEGF-A and eNOS deficiency is necessary and sufficient to induce Kimmelstiel-Wilson-like
nodular glomerulosclerosis in mice through a process that involves deposition of
laminin and
collagen IV and de-nitrosylation of
laminin.